Acetyl-L-carnitine as an adjunctive therapy in the treatment of attention-deficit/hyperactivity disorder in children and adolescents: A placebo-controlled trial

Child Psychiatry and Human Development

Volumn 42, Issue 3, 2011, Pages 367-375

  Abbasi, Seyed Hesameddin ^a   Heidari, Shahram ^b   Mohammadi, Mohammad Reza ^b   Tabrizi, Mina ^c   Ghaleiha, Ali ^d   Akhondzadeh, Shahin ^b  

^a NATIONAL IRANIAN OIL COMPANY   (Iran)

^b TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d HAMADAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Acetyl L carnitine; ADHD; Clinical trial; Methylphenidate

Indexed keywords

ACETYLCARNITINE; NOOTROPIC AGENT;

ADOLESCENT; ANALYSIS OF VARIANCE; ARTICLE; ATTENTION DEFICIT DISORDER; CHILD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DRUG ADMINISTRATION; FEMALE; HUMAN; MALE; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME;

ACETYLCARNITINE; ADOLESCENT; ANALYSIS OF VARIANCE; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; CHILD; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; FEMALE; HUMANS; MALE; NOOTROPIC AGENTS; TREATMENT OUTCOME;

EID: 79959747146     PISSN: 0009398X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10578-011-0220-y     Document Type: Article

References (22)

1. Noorbala AA, Akhondzadeh S (2006) Attention-deficit/hyperactivity disorder: etiology and pharmacotherapy. Arch Iranian Med 9:374-380
2. Mohammadi MR, Akhondzadeh S (2007) Pharmacotherapy of attention-deficit/hyperactivity disorder: nonstimulant medication approaches. Exp Rev Neurotrapeutics 7:195-201 (Pubitemid 46434167)
3. Curatolo P, Paloscia C, D'Agati E, Moavero R, Pasini A (2009) The neurobiology of attention deficit/hyperactivity disorder. Eur J Paediatr Neurol 13:299-304
4. Dopheide JA, Pliszka SR (2009) Attention-deficit-hyperactivity disorder: an update. Pharmacotherapy 29:656-679
5. Adriani W, Rea M, Baviera M, Invernizzi W, Carli M, Ghirardi O, Caprioli A, Laviola G (2004) Acetyl- L-carnitine reduces impulsive behaviour in adolescent rats. Psychopharmacology (Berl) 176:296-304 (Pubitemid 40012736)
6. Rebouche CJ (2004) Kinetics, pharmacokinetics, and regulation of L-carnitine and acetyl-L-carnitine metabolism. Ann NY Acad Sci 1033:30-41
7. Van Oudheusden LJ, Scholte HR (2002) Efficacy of carnitine in the treatment of children with attentiondeficit hyperactivity disorder. Prostaglandins Leukot Essent Fatty Acids 67:33-38 (Pubitemid 35222838)
8. Torrioli MG, Vernacotola S, Peruzzi L, Tabolacci E, Mila M, Militerni R, Musumeci S, Ramos FJ, Frontera M, Sorge G, Marzullo E, Romeo G, Vallee L, Veneselli E, Cocchi E, Garbarino E, Moscato U, Chiurazzi P, D'Iddio S, Calvani M, Neri G (2008) A double-blind, parallel, multicenter comparison of L-acetylcarnitine with placebo on the attention deficit hyperactivity disorder in fragileXsyndrome boys. Am J Med Genet A 146:803-812 (Pubitemid 351499783)
9. Arnold LE, Amato A, Bozzolo H, Hollway J, Cook A, Ramadan Y, Crowl L, Zhang D, Thompson S, Testa G, Kliewer V, Wigal T, McBurnett K, Manos M (2007) Acetyl-L-carnitine (ALC) in attention-deficit/hyperactivity disorder: a multi-site, placebo-controlled pilot trial. J Child Adolesc Psychopharmacol 17:791-802
10. American Psychiatric Association (2000) Diagnostic and statistical manual of mental disorders, 4th edn, text revision (DSMIV- TR). American Psychiatric Association, Washington
11. Ghanizadeh A, Mohammadi MR, Yazdanshenas A (2006) Psychometric properties of the Farsi translation of the Kiddie schedule for affective disorders and Schizophrenia- present and lifetime version. BMC Psychiatry 15(6):10
12. DuPaul G, Power T, Anastopoulos A, Reid R (1998) ADHD rating scale-IV. Guilford, New York
13. Akhondzadeh S, Tavakolian R, Davari-Ashtiani R, Arabgol F, Amini H (2003) Selegiline in the treatment of attention-deficit hyperactivity disorder in children: a double-blind and randomized trial. Prog Neuropsychopharmacol Biol Psychiatry 27:841-845 (Pubitemid 36966767)
14. Akhondzadeh S, Mohammadi MR, Khademi M (2004) Zinc sulfate as an adjunct to methylphenidate for the treatment of attention deficit hyperactivity disorder in children: a double blind and randomized trial [ISRCTN64132371]. BMC Psychiatry 8(4):9
15. Amiri S, Mohammadi MR, Mohammadi M, Nouroozinejad GH, Kahbazi M, Akhondzadeh S (2008) Modafinil as a treatment for attention-deficit/ hyperactivity disorder in children and adolescents: a double blind, randomized clinical trial. Prog Neuropsychopharmacol Biol Psychiatry 32:145-149
16. Kahbazi M, Ghoreishi A, Rahiminejad F, Mohammadi MR, Kamalipour A, Akhondzadeh S (2009) A randomized, double-blind and placebo-controlled trial of modafinil in children and adolescents with attention deficit and hyperactivity disorder. Psychiatry Res 168:234-237
17. Salehi B, Imani R, Mohammadi MR, Fallah J, Mohammadi M, Ghanizadeh A, Tasviechi AA, Vossoughi A, Rezazadeh SA, Akhondzadeh S (2010) Ginkgo biloba for attention-deficit/hyperactivity disorder in children and adolescents: a double blind, randomized controlled trial. Prog Neuropsychopharmacol Biol Psychiatry 34:76-80
18. Zarinara AR, Mohammadi MR, Hazrati N, Tabrizi M, Rezazadeh SA, Rezaie F, Akhondzadeh S (2010) Venlafaxine versus methylphenidate in pediatric outpatients with attention deficit hyperactivity disorder: a randomized, double-blind comparison trial. Hum Psychopharmacol 25:530-535
19. Banaschewski T, Roessner V, Dittmann RW, Santosh PJ, Rothenberger A (2004) Non-stimulant medications in the treatment of ADHD. Eur Child Adolesc Psychiatry 13(suppl 1):102-116
20. Arduini A, Denisova N, Virmani A, Avrova N, Federici G, Arrigoni-Martelli E (1994) Evidence for the involvement of carnitine dependent long-chain acyltransferases in neuronal triglyceride and phospholipid fatty acid turnover. J Neurochem 62:1530-1538 (Pubitemid 24098106)
21. Richardson AJ, Ross MA (2000) Fatty acid metabolism in neurodevelopmental disorder: a new prospective on associations between attention-deficit/ hyperactivity disorder, dyslexia, dyspraxia and the autistic spectrum. Prostaglandins Leukotr Essent Acids 63:1-9
22. Calvani M, Arrigoni-Martelli E (1999) Attenuation by acetyl-L-carnitine of neurological damage and biochemical derangement following brain ischemia and reperfusion. Int J Tissue React 21:1-6 (Pubitemid 29386085)